Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference
Get Alerts AVNS Hot Sheet
Join SI Premium – FREE
ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET
A live webcast of conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical:Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.
View original content to download multimedia:http://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-virtual-raymond-james-42nd-annual-institutional-investors-conference-301234334.html
SOURCE Avanos Medical
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Flash News: OKX Wallet Users Can Now Access CoreX Via Web Extension
- REBELXL - A Revolutionary Reformer Pilates Franchise Announce the Grand Opening of Its First Studio in Wyckoff, New Jersey
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Raymond James, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!